TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Congress Deluged With Protests From Biomedical Researchers Over Grants Reduction, Budget Cuts February 15, 1985
TCL Archive Breast Cancer Plan Issues Its First RFA, Other Initiatives To Be Announced Soon April 14, 1995
TCL Archive NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer June 28, 2002
